Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study

Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study

Abstract Background Clinical data on patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant are limited, especially on clinical status after the application of antibody therapy. Methods We evaluated clinical status in patients with the SARS-CoV-2 delta...

Full description

Bibliographic Details
Main Authors: Xuejiao Liao, Dapeng Li, Jie Liu, Zhi Liu, Zhenghua Ma, Jingke Dong, Xiangyi Yang, Dan Shu, Jing Yuan, Lei Liu, Zheng Zhang
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Virology Journal
Subjects:
COVID-19
SARS-CoV-2
Antibody therapy
Delta variant
Clinical manifestation
Online Access:https://doi.org/10.1186/s12985-022-01944-6

Internet

https://doi.org/10.1186/s12985-022-01944-6

Similar Items